The goal of this clinical trial is to learn if a shared decision-making tool called SHARE-HF can help more people with heart failure receive guideline-recommended medications. The study includes adults with a type of heart failure called heart failure with reduced ejection fraction (HFrEF), who attend heart function clinics in British Columbia, Canada. The main question it aims to answer is:
\- Does use of SHARE-HF during clinic visits lead to more participants receiving their recommended heart failure medications after 6 months?
Researchers will compare clinics using the SHARE-HF tool to clinics providing usual care to see if the tool helps more participants get their recommended medications.
Participants will use the SHARE-HF web-based tool with their clinician during regular clinic visits. The tool shows participants how their heart failure may affect their health over time, explains their medication options, and helps them and their clinician make treatment decisions together.
Patient in a participating HF clinic;
In-person initial HF clinic visit;
Age 40-85 years;
Heart failure with reduced ejection fraction (HFrEF), as indicated by latest cardiac imaging demonstrating ejection fraction ≤40%.
Previous request to the clinic not to be contacted for research;
Consent opt-out;
Non-BC residents;
Residents of long-term care facilities or hospice;
Parallel
SHARE-HF decision aid
Other interventionWeb-based, interactive decision aid that: (1) provides individualized prognosis based on a validated clinical prediction model; (2) presents evidence-based medication options aligned with guidelines; and (3) quantifies benefits and downsides across six patient-prioritized features.
Efficacy-weighted HFrEF guideline-directed medical therapy (GDMT) score
Scores range from 0 to 8, with a higher score indicating greater (better) GDMT utilization.
Worsening heart failure events
Adherence to HFrEF GDMT
Average percent concordance between prescribed and dispensed prescriptions for GDMT
Utilization of individual HFrEF medication classes at any dose
Provider workload and burnout
Brief clinician survey, including a validated single-item measure of self-reported burnout.
Healthcare utilization
* Annualized HF clinic follow-up visits per patient * Total physician encounters per patient
Reach (RE-AIM framework)
Number of patients at each participating clinic with documented use of SHARE-HF during the intervention period.
Adoption (RE-AIM framework)
* Proportion of participating clinics with documented use of SHARE-HF during each intervention period; * Proportion of individual clinicians with documented use of SHARE-HF during each intervention period * Number of documented uses of SHARE-HF by each HF clinic in BC during in the trial
Click on the lead sponsor to view all of their trials.
University of British Columbia
Lead sponsor
Providence Healthcare
Collaborator
Vancouver Coastal Health
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
